<experiments total-assays="630" total-samples="686" total="11" revision="080925" version="1.1"><experiment><id>1778081321</id><accession>E-MEXP-2280</accession><name>Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways</name><releasedate>2009-08-03</releasedate><species>Homo sapiens</species><samples>31</samples><assays>31</assays><sampleattribute><category>Age</category><value>57 years</value><value>61 years</value><value>64 years</value><value>68 years</value><value>70 years</value><value>72 years</value><value>73 years</value><value>74 years</value><value>75 years</value><value>77 years</value><value>78 years</value><value>80 years</value><value>82 years</value><value>83 years</value><value>93 years</value></sampleattribute><sampleattribute><category>BioSourceType</category><value>frozen_sample</value></sampleattribute><sampleattribute><category>ClinicalHistory</category><value>Cause of death: heart attack</value><value>Cause of death: heart failure</value><value>Cause of death: myocardial infarction</value><value>Cause of death: pancreatic cancer</value><value>Disease duration: 10 years; Cause of death: cachexia following swallowing disturbances</value><value>Disease duration: 11 years; Cause of death: pneumonia in a dehydrated and cachexic patient</value><value>Disease duration: 12 years; Cause of death: bronchopneumonia</value><value>Disease duration: 12 years; Cause of death: sepsis, due to an urinary tract infection, and cachexia</value><value>Disease duration: 13 years; Cause of death: cachexia and dehydration</value><value>Disease duration: 14 years; Cause of death: infection of lungs</value><value>Disease duration: 15 years; Cause of death: aspiration pneumonia</value><value>Disease duration: 15 years; Cause of death: dehydration</value><value>Disease duration: 16 years; Cause of death: acute cardiac arrest</value><value>Disease duration: 2 years; Cause of death: euthanasia</value><value>Disease duration: 3 years; Cause of death: cachexia and dehydration</value><value>Disease duration: 3 years; Cause of death: pneumonia / cachexia</value><value>Disease duration: 3 years; Cause of death: respiratory insufficience</value><value>Disease duration: 4 years; Cause of death: complications secondary to a cerebro vasculair accident</value><value>Disease duration: 4 years; Cause of death: septic with a urinary infection</value><value>Disease duration: 6 years; Cause of death: bleeding of the stomach</value><value>Disease duration: 6 years; Cause of death: myocardial infarction</value><value>Disease duration: 6 years; Cause of death: pneumonia and cachexia by PSP</value><value>Disease duration: 7 years; Cause of death: dehydration and vascular insufficiency</value><value>Disease duration: 7 years; Cause of death: pulmonary arrest</value><value>Disease duration: 7 years; Cause of death: unknown</value><value>Disease duration: 8 years; Cause of death: aspiration pneumonia</value><value>Disease duration: 8 years; Cause of death: cachexia and dehydration</value><value>Disease duration: 8 years; Cause of death: lungdisorder with fever for 4 weeks</value><value>Disease duration: 9 years; Cause of death: dehydration and respiratory insufficiency</value><value>Disease duration: more than 7 years; Cause of death: general deterioration</value></sampleattribute><sampleattribute><category>ClinicalInformation</category><value>post mortem delay 3:25</value><value>post mortem delay 3:35</value><value>post mortem delay 3:45</value><value>post mortem delay 3:55</value><value>post mortem delay 4:15</value><value>post mortem delay 4:20</value><value>post mortem delay 4:40</value><value>post mortem delay 4:50</value><value>post mortem delay 5:00</value><value>post mortem delay 5:10</value><value>post mortem delay 5:15</value><value>post mortem delay 5:20</value><value>post mortem delay 5:30</value><value>post mortem delay 5:43</value><value>post mortem delay 5:48</value><value>post mortem delay 6:15</value><value>post mortem delay 6:45</value><value>post mortem delay 7:40</value><value>post mortem delay 7:55</value><value>post mortem delay 8:10</value><value>post mortem delay 8:55</value></sampleattribute><sampleattribute><category>DevelopmentalStage</category><value>adult</value></sampleattribute><sampleattribute><category>DiseaseStaging</category><value>Braak stage 0</value><value>Braak stage 1</value><value>Braak stage 2</value><value>Braak stage 6</value><value>Constantinides type A</value><value>Constantinides type C1</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>Alzheimer's disease</value><value>normal</value><value>Pick's disease</value><value>Progressive supranuclear palsy</value></sampleattribute><sampleattribute><category>Haplotype</category><value>APOE haplotype: 32; MAPT haplotype: H1/H1</value><value>APOE haplotype: 33; MAPT haplotype: H1/H1</value><value>APOE haplotype:33; MAPT haplotype: H1/H2</value><value>APOE haplotype: 33; MAPT haplotype: H1/H2</value><value>APOE haplotype: 42; MAPT haplotype: H1/H1</value><value>APOE haplotype:43; MAPT haplotype: H1/H1</value><value>APOE haplotype: 43; MAPT haplotype: H1/H1</value><value>APOE haplotype: 43; MAPT haplotype: H1/H2</value><value>APOE haplotype:43; MAPT haplotype: H2/H2</value><value>APOE haplotype: 44; MAPT haplotype: H1/H1</value><value>APOE haplotype: 44; MAPT haplotype: H1/H2</value></sampleattribute><sampleattribute><category>Individual</category><value>00-044</value><value>00-066</value><value>00-086</value><value>00-096</value><value>00-099</value><value>00-140</value><value>00-142</value><value>01-021</value><value>01-028</value><value>01-091</value><value>02-062</value><value>03-049</value><value>89-073</value><value>95-069</value><value>95-086</value><value>95-099</value><value>96-012</value><value>96-064</value><value>96-094</value><value>96-098</value><value>96-119</value><value>97-051</value><value>97-072</value><value>98-029</value><value>98-075</value><value>98-101</value><value>98-119</value><value>98-159</value><value>98-163</value><value>99-050</value><value>99-116</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>medial temporal lobe</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><experimentalfactor><name>DiseaseStaging</name><value>Braak stage 0</value><value>Braak stage 1</value><value>Braak stage 2</value><value>Braak stage 6</value><value>Constantinides type A</value><value>Constantinides type C1</value><value>stage unknown</value></experimentalfactor><experimentalfactor><name>DiseaseState</name><value>Alzheimer's disease</value><value>normal</value><value>Pick's disease</value><value>Progressive supranuclear palsy</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>1</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>1</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>5</overallscore></miamescores><bioassaydatagroup><id>1778082078</id><name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name><bioassaydatacubes>31</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>CELv4</dataformat><bioassays>31</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1778082079</id><name>ebi.ac.uk:MAGETabulator:E-MEXP-2280.A-AFFY-44.1.CompositeSequenceDimension</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>31</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><title>Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways</title></bibliography><provider><contact>Iraad Bronner</contact><email>ibronner@mrc-lmb.cam.ac.uk</email><role>submitter</role></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>disease state</experimentdesign><experimentdesign>replicate</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1778081329</id><text>We have constructed genome wide expression profiles from snap frozen post-mortem tissue from the medial temporal lobe of patients with four neurodegenerative disorders (5 AD, 5 PSP, 5 PiD and 5 FTD patients) and 5 control subjects. All patients were matched for age, gender, ApoE-? and MAPT (tau) haplotype. From all groups a total of 790 probes were shown to be differently expressed when compared to control individuals. The results from these experiments were then used to investigate the correlations between clinical, pathological and molecular findings. From the 790 identified probes we extracted a gene set of 166 probes whose expression could discriminate between these disorders and normal ageing. This gene set can be further developed into an accurate microarray-based classification test. Furthermore, from this dataset we extracted a disease specific set of genes and identified two aging related transcription factors (FOXO1A and FOXO3A) as possible drug targets related to neurodegenerative disease.</text></description><description><id>1778082480</id><text>(Generated description) Experiment with 31 hybridizations, using 31 samples of species [Homo sapiens], using 31 arrays of array design [Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 31 raw data files and 1 transformed and/or normalized data files.</text></description><arraydesign><id>405156763</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>31</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="31" count="31" name="E-MEXP-2280.raw.zip"/><fgem count="31" name="E-MEXP-2280.processed.zip"/><idf name="E-MEXP-2280.idf.txt"/><sdrf name="E-MEXP-2280.sdrf.txt"/><biosamples><png name="E-MEXP-2280.biosamples.png"/><svg name="E-MEXP-2280.biosamples.svg"/></biosamples></files></experiment><experiment><id>1743257346</id><accession>E-GEOD-6269</accession><name>Transcription profiling of human blood leukocytes to discriminate patients with acute infections</name><releasedate>2009-03-16</releasedate><species>Homo sapiens</species><samples>143</samples><assays>143</assays><sampleattribute><category>Age</category><value>0.04 years</value><value>0.08 years</value><value>0.13 years</value><value>0.1 years</value><value>0.25 years</value><value>0.38 years</value><value>0.58 years</value><value>0.5 months</value><value>0.5 years</value><value>0.91 years</value><value>1.08 years</value><value>1.25 months</value><value>1.33 years</value><value>1.3 years</value><value>1.5 months</value><value>1.75 years</value><value>1.7 months</value><value>10 months</value><value>10 years</value><value>11 months</value><value>11 years</value><value>12 years</value><value>13 months</value><value>13 years</value><value>14 years</value><value>15 months</value><value>15 years</value><value>16 months</value><value>16 years</value><value>17 months</value><value>18 months</value><value>18 years</value><value>19 months</value><value>1 months</value><value>1 years</value><value>2.5 months</value><value>2.5 years</value><value>20 months</value><value>22 months</value><value>23 months</value><value>24 years</value><value>2 months</value><value>2 years</value><value>3.5 years</value><value>36 years</value><value>3 months</value><value>3 years</value><value>4.5 years</value><value>4 months</value><value>4 years</value><value>5 months</value><value>6 months</value><value>6 years</value><value>7.5 years</value><value>7 months</value><value>7 years</value><value>8 months</value><value>8 years</value><value>9.5 years</value><value>9 months</value><value>9 years</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>abcess</value><value>bacteremia</value><value>bacteremia/septic arthritis/osteomyelitis</value><value>bacteremia/suppurative arthritis</value><value>cellulitis</value><value>disseminated</value><value>disseminated/pneumonia</value><value>encephalitis</value><value>endocarditis/bacteremia</value><value>fever</value><value>fever/seizure</value><value>fever/URI</value><value>fever/URI Sxs</value><value>hip abcess/bacteremia</value><value>lung abcess</value><value>meningitis</value><value>meningitis/bacteremia</value><value>normal</value><value>osteomyelitis</value><value>osteomyelitis/bacteremia</value><value>osteomyelitis/bacteremia/pneumonia</value><value>osteomyelitis/suppurative arthritis</value><value>osteomyelitis/suppurative arthritis/bacteremia</value><value>pneumonia</value><value>pneumonia/bacteremia</value><value>pneumonia/empyema</value><value>pyelonephritis</value><value>respiratory distress</value><value>seizures</value><value>septic arthritis/bacteremia</value><value>septic arthritis/osteomyelitis/bacteremia</value><value>septic athritis</value><value>skin/soft tissue abscess</value><value>skin/soft tissue abscess/bacteremia</value><value>suppurative arthritis</value><value>UTI</value><value>UTI/bacteremia</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><experimentalfactor><name>Compound</name><value>Acyclovir</value><value>Amoxicillin</value><value>Ampicillin/Ceftriaxone</value><value>Ampicillin/Gentamicin</value><value>Ampicillin/Gentamicin/Ceftriaxone</value><value>Cefazolin</value><value>Cefazolin/Rifampin</value><value>Ceftriaxone</value><value>Ceftriaxone/Acyclovir/Oseltamivir</value><value>Ceftriaxone/Azithromycin</value><value>Ceftriaxone/Clindamycin</value><value>Ceftriaxone/Gentamicin</value><value>Ceftriaxone/Oseltamivir</value><value>Ceftriaxone/Vancomycin</value><value>Cefuroxime</value><value>Cefuroxime/Clindamycin</value><value>Cefuroxime/Oseltamivir</value><value>Clindamycin</value><value>Clindamycin/Doxycycline</value><value>Clindamycin/Rifampin</value><value>Gentamicin</value><value>Gentamicin/Ampicillin</value><value>Nafcillin</value><value>none</value><value>Oseltamivir</value><value>Oxacillin</value><value>Oxacillin/Clindamycin</value><value>Oxacillin/Gentamicin/Rifampin</value><value>Oxacillin/Rifampin</value><value>Oxacillin/Tobramycin</value><value>Vancomycin</value><value>Vancomycin/Cefazolin</value><value>Vancomycin/Cefazolin/Gentamicin</value><value>Vancomycin/Ceftriaxone</value><value>Vancomycin/Clindamycin/Rifampin</value><value>Vancomycin/Gentamicin</value><value>Vancomycin/Rifampin</value><value>Vancomycin/Rifampin/Linezolid</value></experimentalfactor><experimentalfactor><name>DiseaseState</name><value>abcess</value><value>bacteremia</value><value>bacteremia/septic arthritis/osteomyelitis</value><value>bacteremia/suppurative arthritis</value><value>cellulitis</value><value>disseminated</value><value>disseminated/pneumonia</value><value>encephalitis</value><value>endocarditis/bacteremia</value><value>fever</value><value>fever/seizure</value><value>fever/URI</value><value>fever/URI Sxs</value><value>hip abcess/bacteremia</value><value>lung abcess</value><value>meningitis</value><value>meningitis/bacteremia</value><value>normal</value><value>osteomyelitis</value><value>osteomyelitis/bacteremia</value><value>osteomyelitis/bacteremia/pneumonia</value><value>osteomyelitis/suppurative arthritis</value><value>osteomyelitis/suppurative arthritis/bacteremia</value><value>pneumonia</value><value>pneumonia/bacteremia</value><value>pneumonia/empyema</value><value>pyelonephritis</value><value>respiratory distress</value><value>seizures</value><value>septic arthritis/bacteremia</value><value>septic arthritis/osteomyelitis/bacteremia</value><value>septic athritis</value><value>skin/soft tissue abscess</value><value>skin/soft tissue abscess/bacteremia</value><value>suppurative arthritis</value><value>UTI</value><value>UTI/bacteremia</value></experimentalfactor><experimentalfactor><name>Infect</name><value>E. coli</value><value>influenza A</value><value>influenza B</value><value>S. aureus</value><value>S. pneumoniae</value><value>uninfected</value></experimentalfactor><secondaryaccession>GSE6269</secondaryaccession><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>1</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>0</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>4</overallscore></miamescores><bioassaydatagroup><id>1743257526</id><name>Affymetrix:FeatureDimension:HG-U133A</name><bioassaydatacubes>97</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>CELv3</dataformat><bioassays>97</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1743257527</id><name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name><bioassaydatacubes>22</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>CELv4</dataformat><bioassays>22</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1743257528</id><name>ebi.ac.uk:MAGETabulator:E-GEOD-6269.HG-U133A.1.CompositeSequenceDimension</name><bioassaydatacubes>97</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>97</bioassays><isderived>1</isderived></bioassaydatagroup><bioassaydatagroup><id>1743257525</id><name>ebi.ac.uk:MAGETabulator:E-GEOD-6269.A-MEXP-691.1.CompositeSequenceDimension</name><bioassaydatacubes>24</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>24</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1743257529</id><name>ebi.ac.uk:MAGETabulator:E-GEOD-6269.A-MEXP-691.1.CompositeSequenceDimension</name><bioassaydatacubes>24</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>24</bioassays><isderived>1</isderived></bioassaydatagroup><bioassaydatagroup><id>1743257530</id><name>ebi.ac.uk:MAGETabulator:E-GEOD-6269.HG-U133_Plus_2.1.CompositeSequenceDimension</name><bioassaydatacubes>22</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>22</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><accession>17105821</accession><authors>Octavio Ramilo, Windy Allman, Wendy Chung, Asuncion Mejias, Monica Ardura, Casey Glaser, Knut M Wittkowski, Bernard Piqueras, Jacques Banchereau, A Karolina Palucka, Damien Chaussabel</authors><title>Gene expression patterns in blood leukocytes discriminate patients with acute infections.</title></bibliography><provider><contact>Damien Chaussabel</contact><email>damienc@baylorhealth.edu</email><role>submitter</role></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>compound treatment</experimentdesign><experimentdesign>disease state</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1743257353</id><text>Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases. Experiment Overall Design: Entire study included 144 samples. Only 143 are included in this series because the CHP/CEL file was not available for sample PBMC_Healthy_INF295.</text></description><description><id>1743257531</id><text>(Generated description) Experiment with 143 hybridizations, using 143 samples of species [Homo sapiens], using 143 arrays of array design [Illumina Human-6 v1 Expression BeadChip, Affymetrix GeneChip  Human Genome HG-U133A [HG-U133A], Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 143 raw data files and 143 transformed and/or normalized data files.</text></description><arraydesign><id>302382080</id><accession>A-AFFY-33</accession><name>Affymetrix GeneChip  Human Genome HG-U133A [HG-U133A]</name><count>97</count></arraydesign><arraydesign><id>405156763</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>22</count></arraydesign><arraydesign><id>1334201749</id><accession>A-MEXP-691</accession><name>Illumina Human-6 v1 Expression BeadChip</name><count>24</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="119" count="143" name="E-GEOD-6269.raw.zip"/><fgem count="143" name="E-GEOD-6269.processed.zip"/><idf name="E-GEOD-6269.idf.txt"/><sdrf name="E-GEOD-6269.sdrf.txt"/><biosamples><png name="E-GEOD-6269.biosamples.png"/><svg name="E-GEOD-6269.biosamples.svg"/></biosamples></files></experiment><experiment><id>1631580654</id><accession>E-GEOD-8507</accession><name>Transcription profiling of human neutrophil and PBMC gene expression data from Jobs Syndrome individuals</name><releasedate>2008-06-15</releasedate><species>Homo sapiens</species><samples>141</samples><assays>141</assays><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><secondaryaccession>GSE8507</secondaryaccession><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>0</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>1</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>4</overallscore></miamescores><bioassaydatagroup><id>1634124383</id><name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name><bioassaydatacubes>141</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>CELv4</dataformat><bioassays>141</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1634127798</id><name>ebi.ac.uk:Tab2MAGE:E-GEOD-8507.A-AFFY-44.1.CompositeSequenceDimension</name><bioassaydatacubes>141</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>141</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><accession>17881745</accession><publication>N Engl J Med</publication><authors>Steven M Holland, Frank R DeLeo, Houda Z Elloumi, Amy P Hsu, Gulbu Uzel, Nina Brodsky, Alexandra F Freeman, Andrew Demidowich, Joie Davis, Maria L Turner, Victoria L Anderson, Dirk N Darnell, Pamela A Welch, Douglas B Kuhns, David M Frucht, Harry L Malech, John I Gallin, Scott D Kobayashi, Adeline R Whitney, Jovanka M Voyich, James M Musser, Cristina Woellner, Alejandro A Sch ffer, Jennifer M Puck, Bodo Grimbacher</authors><title>STAT3 mutations in the hyper-IgE syndrome.</title><year>2007</year><volume>357</volume><issue>16</issue><pages>1608-19</pages></bibliography><provider><contact>Addie Whitney</contact><email>awhitney@niaid.nih.gov</email><role>submitter</role></provider><experimentdesign>unknown experiment type</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1631580695</id><text>Hyper IgE Recurrent Infection Syndrome (HIES or Job   s syndrome), is a rare disorder of immunity and connective tissue, typically manifest with boils, cyst-forming pneumonias, and extremely elevated serum IgE as well as retained primary dentition and bone abnormalities. Inheritance can be autosomal dominant. In order to identify a specific defect or gene of interest, we performed microarray expression analysis on samples from patients with Job's syndrome and from healthy control subjects. Experiment Overall Design: Polymorphonuclear leukocytes (PMNs) and peripheral blood mononuclear cells (PBMCs) were isolated from whole blood from patients with Job's syndrome and healthy control subjects.  PMNs and PBMCs were incubated with or without IgG- and C3bi-coated latex beads for 3 and 6 hours.</text></description><description><id>1634135209</id><text>(Generated description) Experiment with 141 hybridizations, using 141 samples of species [Homo sapiens], using 141 arrays of array design [Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 141 raw data files and 141 transformed and/or normalized data files.</text></description><arraydesign><id>405156763</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>141</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="141" count="141" name="E-GEOD-8507.raw.zip"/><fgem count="141" name="E-GEOD-8507.processed.zip"/><idf name="E-GEOD-8507.idf.txt"/><sdrf name="E-GEOD-8507.sdrf.txt"/><biosamples><png name="E-GEOD-8507.biosamples.png"/><svg name="E-GEOD-8507.biosamples.svg"/></biosamples></files></experiment><experiment><id>1631491695</id><accession>E-GEOD-8527</accession><name>Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci</name><releasedate>2008-06-15</releasedate><species>Homo sapiens</species><samples>32</samples><assays>32</assays><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><secondaryaccession>GSE8527</secondaryaccession><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>0</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>1</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>4</overallscore></miamescores><bioassaydatagroup><id>1631498904</id><name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name><bioassaydatacubes>32</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>CELv4</dataformat><bioassays>32</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1631501517</id><name>ebi.ac.uk:Tab2MAGE:E-GEOD-8527.A-AFFY-44.1.CompositeSequenceDimension</name><bioassaydatacubes>32</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>32</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><accession>17709418</accession><publication>Infect Immun</publication><authors>Hester J Bootsma, Michael Egmont-Petersen, Peter W M Hermans</authors><title>Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: evidence for a distinct response to encapsulated strains.</title><year>2007</year><volume>75</volume><issue>11</issue><pages>5489-99</pages></bibliography><provider><contact>Hester Bootsma</contact><email>h.bootsma@cukz.umcn.nl</email><role>submitter</role></provider><experimentdesign>unknown experiment type</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1631491714</id><text>Infection of the human host by Streptococcus pneumoniae begins with colonization of the nasopharynx, which is mediated by adherence of bacteria to respiratory epithelium. Several studies have indicated an important role for the pneumococcal capsule in this process. Here, we used microarrays to characterize the in vitro transcriptional response of human nasopharyngeal epithelial Detroit 562 cells to adherence of serotype 2-encapsulated strain D39, serotype 19F-encapsulated strain G54, serotype 4-encapsulated strain TIGR4, and their nonencapsulated derivatives (  cps). In total, 322 genes were found to be upregulated in response to adherent pneumococci. Twenty-two genes were commonly induced, including those encoding several cytokines (e.g., IL-1  , IL-6), chemokines (e.g., IL-8, CXCL1/2), and transcriptional regulators (e.g., FOS), consistent with an innate immune response mediated by Toll-like receptor signaling. Interestingly, 85% of genes was induced specifically by one or more encapsulated strains, suggestive of a capsule-dependent response. Importantly,  purified capsular polysaccharides alone had no effect. Over a third of these loci encoded products predicted to be involved in transcriptional regulation and signal transduction, in particular MAPK signaling pathways. Real-time PCR of a subset of ten genes confirmed microarray data and showed a time-dependent upregulation of especially innate immunity genes. Downregulation of epithelial genes was most pronounced upon adherent D39  cps, as 68% of the 161 genes identified was only repressed using this nonencapsulated strain. In conclusion, we identified a subset of host genes specifically induced by encapsulated strains during in vitro adherence, and have demonstrated the complexity of interactions occurring during the initial stages of pneumococcal infection. Experiment Overall Design: We used three different pneumococcal strains and their isogenic nonencapsulated derivatives (  cps): serotype 2-encapsulated strain D39, serotype 19F-encapsulated strain G54, and serotype 4-encapsulated strain TIGR4. All experiments were performed in triplicate (3 independent biological replicates) and compared to uninfected control Detroit 562 cells. Bacteria were allowed to adhere to the epithelial cells for 2 hours, after which the transcriptional response of the Detroit cells was analyzed using Affymetrix Human U133 Plus GeneChips. In addition to the 6 strains mentioned above, we included transcriptional analysis of the epithelial cell response to low-dose D39  cps (giving adherence equivalent to wild-type D39) and purified type 2 capsular polysaccharides.</text></description><description><id>1631520355</id><text>(Generated description) Experiment with 32 hybridizations, using 32 samples of species [Homo sapiens], using 32 arrays of array design [Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 32 raw data files and 32 transformed and/or normalized data files.</text></description><arraydesign><id>405156763</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>32</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="32" count="32" name="E-GEOD-8527.raw.zip"/><fgem count="32" name="E-GEOD-8527.processed.zip"/><idf name="E-GEOD-8527.idf.txt"/><sdrf name="E-GEOD-8527.sdrf.txt"/><biosamples><png name="E-GEOD-8527.biosamples.png"/><svg name="E-GEOD-8527.biosamples.svg"/></biosamples></files></experiment><experiment><id>1629886673</id><accession>E-GEOD-7246</accession><name>Transcription profiling of human epithelial cell line (HL) infected with Chlamydia pneumoniae</name><releasedate>2008-06-14</releasedate><species>Homo sapiens</species><samples>16</samples><assays>8</assays><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><secondaryaccession>GSE7246</secondaryaccession><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>0</factorvaluescore><measuredbioassaydatascore>0</measuredbioassaydatascore><protocolscore>0</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>2</overallscore></miamescores><bioassaydatagroup><id>1629901610</id><name>ebi.ac.uk:Tab2MAGE:E-GEOD-7246.A-AGIL-9.1.ReporterDimension</name><bioassaydatacubes>8</bioassaydatacubes><arraydesignprovider>AGIL</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>8</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><pages>-</pages></bibliography><provider><contact>Dario Greco</contact><email>dario.greco@helsinki.fi</email><role>submitter</role></provider><experimentdesign>unknown experiment type</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1629913182</id><text>(Generated description) Experiment with 8 hybridizations, using 16 samples of species [Homo sapiens], using 8 arrays of array design [Agilent Human 1A Microarray(V2)[G4110B]], producing 0 raw data files and 8 transformed and/or normalized data files.</text></description><description><id>1629887091</id><text>Transcriptional profiling of human epithelial cell line (HL) infected with Chlamydia penumoniae compared to control cells at time points 12h, 24h, 48h, 72h after the infection. Experiment Overall Design: Two-condition experiment over the time. Biological replicates: 2 infected, 2 controls at each time point (12h, 24h, 48h, and 72h), independently grown.</text></description><arraydesign><id>374659329</id><accession>A-AGIL-9</accession><name>Agilent Human 1A Microarray (V2) 012097 G4110B</name><count>8</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="0" count="0" name="E-GEOD-7246.raw.zip"/><fgem count="8" name="E-GEOD-7246.processed.zip"/><idf name="E-GEOD-7246.idf.txt"/><sdrf name="E-GEOD-7246.sdrf.txt"/><biosamples><png name="E-GEOD-7246.biosamples.png"/><svg name="E-GEOD-7246.biosamples.svg"/></biosamples></files></experiment><experiment><id>1626042665</id><accession>E-MEXP-1613</accession><name>Transcription profiling of human peripheral monocytes infected with three gram-positive bacterial pathogens (Listeria monocytogenes, Staphylococcus aureus and Streptococcus pneumoniae)</name><releasedate>2008-06-10</releasedate><species>Homo sapiens</species><samples>40</samples><assays>40</assays><sampleattribute><category>BioSourceType</category><value>fresh_sample</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>L. monocytogenes infected</value><value>normal</value><value>S. aureus infected</value><value>S. pneumoniae infected</value></sampleattribute><sampleattribute><category>Individual</category><value>D20</value><value>D21</value><value>D22</value><value>D23</value><value>D24</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>blood</value></sampleattribute><sampleattribute><category>TargetedCellType</category><value>peripheral blood monocytes</value></sampleattribute><experimentalfactor><name>DiseaseState</name><value>L. monocytogenes infected</value><value>normal</value><value>S. aureus infected</value><value>S. pneumoniae infected</value></experimentalfactor><experimentalfactor><name>Individual</name><value>D20</value><value>D21</value><value>D22</value><value>D23</value><value>D24</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>0</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>1</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>4</overallscore></miamescores><bioassaydatagroup><id>1626042815</id><name>ebi.ac.uk:MAGETabulator:E-MEXP-1613.A-MEXP-162.1.ReporterDimension</name><bioassaydatacubes>40</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>40</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1626042846</id><name>ebi.ac.uk:MAGETabulator:E-MEXP-1613.A-MEXP-162.2.ReporterDimension</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>40</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography/><provider><contact>Rohit Ghai</contact><email>Rohit.Ghai@mikrobio.med.uni-giessen.de</email><role>submitter</role></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>disease state</experimentdesign><experimentdesign>replicate</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1626042673</id><text>Initial transcriptional response of human peripheral monocytes infected with a set of three gram-positive bacterial pathogens (Listeria monocytogenes, Staphylococcus aureus and Streptococcus pneumoniae). Monocytes were isolated from five probands.</text></description><description><id>1626043126</id><text>(Generated description) Experiment with 40 hybridizations, using 40 samples of species [Homo sapiens], using 40 arrays of array design [Amersham CodeLink  UniSet Human 10K I Bioarray], producing 40 raw data files and 1 transformed and/or normalized data files.</text></description><arraydesign><id>418256071</id><accession>A-MEXP-162</accession><name>Amersham CodeLink  UniSet Human 10K I Bioarray</name><count>40</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="0" count="40" name="E-MEXP-1613.raw.zip"/><fgem count="40" name="E-MEXP-1613.processed.zip"/><idf name="E-MEXP-1613.idf.txt"/><sdrf name="E-MEXP-1613.sdrf.txt"/><biosamples><png name="E-MEXP-1613.biosamples.png"/><svg name="E-MEXP-1613.biosamples.svg"/></biosamples></files></experiment><experiment><id>1605345879</id><accession>E-GEOD-6377</accession><name>Transcription profiling of human patients suffering FROM bacterial infections TO investigate plasticity OF THE systemic inflammatory response TO acute infection during critical illness</name><releasedate>2008-04-08</releasedate><species>Homo sapiens</species><samples>99</samples><assays>99</assays><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><secondaryaccession>GSE6377</secondaryaccession><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>0</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>1</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>4</overallscore></miamescores><bioassaydatagroup><id>1605345903</id><name>Affymetrix:FeatureDimension:HG-Focus</name><bioassaydatacubes>99</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>CELv3</dataformat><bioassays>99</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1605345904</id><name>ebi.ac.uk:Tab2MAGE:E-GEOD-6377.A-AFFY-41.1.CompositeSequenceDimension</name><bioassaydatacubes>99</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>99</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><pages>-</pages></bibliography><provider><contact>J Perren Cobb</contact><email>cobb@wustl.edu</email><role>submitter</role></provider><experimentdesign>unknown experiment type</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1605345886</id><text>Diagnosis of acute infection in the critically ill remains a challenge. Changes in physiologic parameters and existing molecular diagnostics are not specific and microbiologic confirmation of infection can take days. As cellular first responders, preclinical studies indicate that circulating leukocytes are activated in response to bacterial infection, manifesting infection-specific transcriptional programs.  We hypothesized that circulating leukocyte transcriptional profiles can be used to diagnose infection and monitor response to therapy in the critically ill. Experiment Overall Design: A translational research approach was employed.  Fifteen mice underwent intratracheal (i.t.) injections of live P. aeruginosa, P. aeruginosa endotoxin, live S. pneumoniae, or normal saline. At 24 hours after injury, GeneChip microarray analysis of circulating buffy coat RNA identified 219 genes that distinguished between the pulmonary insults and differences in 7-day mortality. Similarly, buffy coat microarray expression profiles were generated from 20 mechanically ventilated patients every two days for up to three weeks; 11 of these patients developed pneumonia.  Principal components analysis of the expression levels of the human orthologs for the mouse genes resulted in gene expression trajectories that describe the cohort of 11 patients as they develop, are treated for, and convalesce from ventilator-associated pneumonia (VAP).  When the VAP microarray profiles were analyzed independently, 85 genes were identified with consistent changes in abundance during the seven days bracketing the diagnosis of VAP.  The estimated prediction accuracy in this small patient cohort was 91%.  The abundance of select transcripts was validated using real-time PCR. Principal components analysis of the average microarray-measured abundances of these genes defined a general trajectory (riboleukogram) for the onset of acute infection in this patient population. Individual riboleukograms demonstrated that the onset and course of infection are specific for each individual, but as patients recover from infection the riboleukograms converge.  The gene ontologies of the co-expression networks indicate that leukocyte chemokines and granule maturation are especially informative for pneumonia diagnostics.</text></description><description><id>1605345927</id><text>(Generated description) Experiment with 99 hybridizations, using 99 samples of species [Homo sapiens], using 99 arrays of array design [Affymetrix GeneChip  Human Genome Focus Array [HG-Focus]], producing 99 raw data files and 99 transformed and/or normalized data files.</text></description><arraydesign><id>327974795</id><accession>A-AFFY-41</accession><name>Affymetrix GeneChip  Human Genome Focus Array [HG-Focus]</name><count>99</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="99" count="99" name="E-GEOD-6377.raw.zip"/><fgem count="99" name="E-GEOD-6377.processed.zip"/><idf name="E-GEOD-6377.idf.txt"/><sdrf name="E-GEOD-6377.sdrf.txt"/><biosamples><png name="E-GEOD-6377.biosamples.png"/><svg name="E-GEOD-6377.biosamples.svg"/></biosamples></files></experiment><experiment><id>1603806167</id><accession>E-MEXP-1477</accession><name>Transcription profiling of human pneumocytes after injury caused by wild type, descapsulated mutant and LPS O-Chain mutant Klebsiella pneumoniae strains at different time points</name><releasedate>2008-03-31</releasedate><species>Homo sapiens</species><samples>50</samples><assays>96</assays><sampleattribute><category>CellLine</category><value>A549</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>TargetedCellType</category><value>pneumocyte</value></sampleattribute><experimentalfactor><name>EnvironmentalStress</name><value>descapsulated mutant Klebsiella</value><value>LPS-O-Chain(-) Klebsiella</value><value>mixed Klebsiella strains</value><value>none</value><value>wild type Klebsiella</value></experimentalfactor><experimentalfactor><name>time</name><value>0</value><value>10</value><value>4</value><value>6</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>1</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>0</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>4</overallscore></miamescores><bioassaydatagroup><id>1603806200</id><name>ebi.ac.uk:MIAMExpress:FeatureDimension:36764</name><bioassaydatacubes>96</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>Tab delimited</dataformat><bioassays>96</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1603806201</id><name>ebi.ac.uk:MIAMExpress:ReporterDimension:4219.exp_derived</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>Tab delimited</dataformat><bioassays>96</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><pages>-</pages></bibliography><provider><contact>Javier Margareto</contact><email>javierm@leia.es</email><role>submitter</role></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>injury</experimentdesign><experimentdesign>reference</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1603806172</id><text>Response of Epithelial cells to the injury caused by different Klebsiella strains at different time points. K. pneumoniae strains used are: Wild type, Descapsulated mutant and LPS O-Chain mutant. Time points considered are: 4 hr, 6 hr and 10 hr</text></description><description><id>1603806173</id><text/></description><description><id>1603806202</id><text>(Generated description) Experiment with 96 hybridizations, using 50 samples of species [Homo sapiens], using 96 arrays of array design [Agilent Whole Human Genome Microarray 4x44K (alternative layout)], producing 96 raw data files and 1 transformed and/or normalized data files.</text></description><arraydesign><id>1599794162</id><accession>A-MEXP-1125</accession><name>Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (266 cols x 170 rows)</name><count>96</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="0" count="96" name="E-MEXP-1477.raw.zip"/><fgem count="96" name="E-MEXP-1477.processed.zip"/><idf name="E-MEXP-1477.idf.txt"/><sdrf name="E-MEXP-1477.sdrf.txt"/><biosamples><png name="E-MEXP-1477.biosamples.png"/><svg name="E-MEXP-1477.biosamples.svg"/></biosamples></files></experiment><experiment><id>1463791472</id><accession>E-GEOD-1724</accession><name>Transcription profiling of human lung fibroblasts isolated from pulmonary fibrosis patients and treated with TGF beta</name><releasedate>2007-08-03</releasedate><species>Homo sapiens</species><samples>18</samples><assays>18</assays><sampleattribute><category>CellType</category><value>fibroblast</value></sampleattribute><sampleattribute><category>DevelopmentalStage</category><value>fetus</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>idiopathic pulmonary fibrosis</value><value>normal</value><value>scleroderma-associated pulmonary fibrosis</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>lung</value></sampleattribute><experimentalfactor><name>Compound</name><value>none</value><value>TGF beta</value></experimentalfactor><experimentalfactor><name>DiseaseState</name><value>idiopathic pulmonary fibrosis</value><value>normal</value><value>scleroderma-associated pulmonary fibrosis</value></experimentalfactor><secondaryaccession>GSE1724</secondaryaccession><secondaryaccession>GDS1012</secondaryaccession><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>1</factorvaluescore><measuredbioassaydatascore>0</measuredbioassaydatascore><protocolscore>1</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>4</overallscore></miamescores><bioassaydatagroup><id>1463791823</id><name>ebi.ac.uk:Tab2MAGE:E-GEOD-1724.A-AFFY-1.1.CompositeSequenceDimension</name><bioassaydatacubes>18</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>18</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><pages>-</pages></bibliography><provider><contact>Elisabetta Augusta Renzoni</contact><email>e.renzoni@imperial.ac.uk</email><role>submitter</role></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>compound treatment</experimentdesign><experimentdesign>disease state</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1463791479</id><text>The response to a 4 hour treatment with TGFbeta (4 ng/ml) was evaluated in lung fibroblasts derived from three controls (normal periphery of resected tumor), open lung biopsies from three patients with idiopathic pulmonary fibrosis (usual interstitial pneumonia pattern on biopsy) and from three patients with fibrosing alveolitis associated with systemic sclerosis (fibrotic non specific interstitial pneumonia pattern on biopsy). Lung fibroblasts were grown to confluence in DMEM with 10% fetal calf serum. At confluence, lung fibroblasts were serum-deprived overnight, and exposed to either 4 ng/ml of activated TGF-  1 (R&amp;D Systems) or serum-free culture medium with 0.1% BSA for four hours.</text></description><description><id>1463792230</id><text>(Generated description) Experiment with 18 hybridizations, using 18 samples of species [Homo sapiens], using 18 arrays of array design [Affymetrix GeneChip  Human Genome U95Av2 [HG_U95Av2]], producing 0 raw data files and 18 transformed and/or normalized data files.</text></description><arraydesign><id>5728564</id><accession>A-AFFY-1</accession><name>Affymetrix GeneChip  Human Genome U95Av2 [HG_U95Av2]</name><count>18</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="0" count="0" name="E-GEOD-1724.raw.zip"/><fgem count="18" name="E-GEOD-1724.processed.zip"/><idf name="E-GEOD-1724.idf.txt"/><sdrf name="E-GEOD-1724.sdrf.txt"/><biosamples><png name="E-GEOD-1724.biosamples.png"/><svg name="E-GEOD-1724.biosamples.svg"/></biosamples></files></experiment><experiment><id>1435127447</id><accession>E-MEXP-1078</accession><name>Transcription profiling of human HeLa cells treated with major listerial toxin listeriolysin</name><releasedate>2007-06-23</releasedate><species>Homo sapiens</species><samples>6</samples><assays>6</assays><sampleattribute><category>BioSourceType</category><value>fresh_sample</value></sampleattribute><sampleattribute><category>CellLine</category><value>HeLa</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>cervix epithelium</value></sampleattribute><experimentalfactor><name>Compound</name><value>listeriolysin</value></experimentalfactor><experimentalfactor><name>dose</name><value>0</value><value>6</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><factorvaluescore>1</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>0</protocolscore><derivedbioassaydatascore>1</derivedbioassaydatascore><overallscore>4</overallscore></miamescores><bioassaydatagroup><id>1435127467</id><name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name><bioassaydatacubes>6</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>CELv4</dataformat><bioassays>6</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1435127466</id><name>ebi.ac.uk:MIAMExpress:CompositeSequenceDimension:exp_derived:3250</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider>AFFY</arraydesignprovider><dataformat>Tab delimited</dataformat><bioassays>6</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><accession>17675409</accession><publication>Proc Natl Acad Sci U S A</publication><authors>Hamon MA, Batsch  E, R gnault B, Tham TN, Seveau S, Muchardt C, Cossart P</authors><title>Histone modifications induced by a family of bacterial toxins</title><year>2007</year><volume>104</volume><issue>33</issue><pages>13467-72</pages></bibliography><provider><contact>Melanie Hamon</contact><email>hamon@pasteur.fr</email><role>submitter</role></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>compound treatment</experimentdesign><experimentdesign>in vitro</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1435127453</id><text/></description><description><id>1435127452</id><text>Upon infection, pathogens reprogram host gene expression. In eukaryotic cells, genetic reprogramming is induced by the concerted activation/repression of transcription factors and various histone modifications that control DNA accessibility in chromatin. We report  here that the bacterial pathogen, Listeria monocytogenes, induces a dramatic dephosphorylation of histone H3 as well as a deacetylation of histone H4 during early phases of infection. This effect is mediated by the major listerial toxin listeriolysin (LLO), in a pore forming independent manner. Strikingly, a similar effect is also observed with other toxins of the same family, such as Clostridium perfringens perfringolysin (PFO) and Streptococcus pneumoniae pneumolysin (PLY). The decreased levels of histone modifications correlate with a reduced transcriptional activity of a subset of host   genes, including key immunity genes. Thus, manipulation of the epigenetic information emerges here as an unsuspected function shared by several bacterial toxins, highlighting a common strategy used by intracellular and extracellular pathogens to modulate the host response early during infection.  </text></description><description><id>1435127468</id><text>(Generated description) Experiment with 6 hybridizations, using 6 samples of species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 1 transformed and/or normalized data files.</text></description><arraydesign><id>405156763</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip  Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>6</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="6" count="6" name="E-MEXP-1078.raw.zip"/><fgem count="6" name="E-MEXP-1078.processed.zip"/><idf name="E-MEXP-1078.idf.txt"/><sdrf name="E-MEXP-1078.sdrf.txt"/><biosamples><png name="E-MEXP-1078.biosamples.png"/><svg name="E-MEXP-1078.biosamples.svg"/></biosamples></files></experiment><experiment><id>1207811864</id><accession>E-MEXP-857</accession><name>Transcription profiling of brain samples from human control and schizophrenia patients who were treated with either typical, atypical or no antipsychotic medication</name><releasedate>2006-10-06</releasedate><species>Homo sapiens</species><samples>110</samples><assays>16</assays><sampleattribute><category>Age</category><value>20</value><value>21</value><value>21.5</value><value>24</value><value>25</value><value>26</value><value>29</value><value>30</value><value>31</value><value>32</value><value>34</value><value>35</value><value>40</value><value>41</value><value>42</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>62</value><value>63</value><value>64</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>80</value><value>81</value><value>82</value><value>84</value><value>85</value><value>86</value><value>87</value><value>90</value><value>96</value></sampleattribute><sampleattribute><category>BioSourceType</category><value>frozen_sample</value></sampleattribute><sampleattribute><category>ClinicalHistory</category><value>Cause of death: accidental drowning</value><value>Cause of death: acute alcohol intoxication</value><value>Cause of death: acute liver failure</value><value>Cause of death: acute pulmonary oedema</value><value>Cause of death: aortic aneurism</value><value>Cause of death: bronchopenumonia</value><value>Cause of death: bronchopneumonia</value><value>Cause of death: cardiac</value><value>Cause of death: cardiorespiratory failure</value><value>Cause of death: cardiovascular accident</value><value>Cause of death: chronic ischaemic heart disease</value><value>Cause of death: coronary artery occlusion</value><value>Cause of death: gastrointestinal bleed</value><value>Cause of death: haemathorax</value><value>Cause of death: haemopericardium</value><value>Cause of death: intra-abominal sepsis</value><value>Cause of death: ischaemic heart disease</value><value>Cause of death: left ventricular failure</value><value>Cause of death: motor vehicle accident</value><value>Cause of death: multiple injuries</value><value>Cause of death: multiple organ failure</value><value>Cause of death: mycocardial infarction</value><value>Cause of death: n/a</value><value>Cause of death: pelvic carcinoma</value><value>Cause of death: perforated duodenal</value><value>Cause of death: peritonitis</value><value>Cause of death: pneumonia</value><value>Cause of death: pulmonary disease</value><value>Cause of death: pulmonary emblous</value><value>Cause of death: pulmonary embolism</value><value>Cause of death: pulmonary embolus</value><value>Cause of death: pulmonary infarction</value><value>Cause of death: pulmonary oedema</value><value>Cause of death: pulmonary tuberculosis</value><value>Cause of death: ruptured aortic aneurism</value><value>Cause of death: sudden accident</value><value>Cause of death: suicide</value><value>Cause of death: unknown</value><value>Cause of death: unknown </value><value>Post-mortem interval: 10.7 hours</value><value>Post-mortem interval: 100 hours</value><value>Post-mortem interval: 10 hours</value><value>Post-mortem interval: 11 hours</value><value>Post-mortem interval: 12 hours</value><value>Post-mortem interval: 13.1 hours</value><value>Post-mortem interval: 13 hours</value><value>Post-mortem interval: 14.2 hours</value><value>Post-mortem interval: 14 hours</value><value>Post-mortem interval: 15.4 hours</value><value>Post-mortem interval: 16 hours</value><value>Post-mortem interval: 17.8 hours</value><value>Post-mortem interval: 18.5 hours</value><value>Post-mortem interval: 18.8 hours</value><value>Post-mortem interval: 19.2 hours</value><value>Post-mortem interval: 19.3 hours</value><value>Post-mortem interval: 19 hours</value><value>Post-mortem interval: 20.5 hours</value><value>Post-mortem interval: 20.7 hours</value><value>Post-mortem interval: 20 hours</value><value>Post-mortem interval: 21.1 hours</value><value>Post-mortem interval: 21.5 hours</value><value>Post-mortem interval: 21.8 hours</value><value>Post-mortem interval: 21 hours</value><value>Post-mortem interval: 22 hours</value><value>Post-mortem interval: 23.3 hours</value><value>Post-mortem interval: 23 hours</value><value>Post-mortem interval: 24 hours</value><value>Post-mortem interval: 25 hours</value><value>Post-mortem interval: 26.4 hours</value><value>Post-mortem interval: 26 hours</value><value>Post-mortem interval: 27.7 hours</value><value>Post-mortem interval: 27 hours</value><value>Post-mortem interval: 28.7 hours</value><value>Post-mortem interval: 28 hours</value><value>Post-mortem interval: 29.5 hours</value><value>Post-mortem interval: 29 hours</value><value>Post-mortem interval: 30 hours</value><value>Post-mortem interval: 31 hours</value><value>Post-mortem interval: 32 hours</value><value>Post-mortem interval: 35 hours</value><value>Post-mortem interval: 36 hours</value><value>Post-mortem interval: 37 hours</value><value>Post-mortem interval: 38 hours</value><value>Post-mortem interval: 40 hours</value><value>Post-mortem interval: 42 hours</value><value>Post-mortem interval: 44 hours</value><value>Post-mortem interval: 45 hours</value><value>Post-mortem interval: 48 hours</value><value>Post-mortem interval: 50 hours</value><value>Post-mortem interval: 51 hours</value><value>Post-mortem interval: 52 hours</value><value>Post-mortem interval: 53 hours</value><value>Post-mortem interval: 60 hours</value><value>Post-mortem interval: 61 hours</value><value>Post-mortem interval: 67 hours</value><value>Post-mortem interval: 7.2 hours</value><value>Post-mortem interval: 70 hours</value><value>Post-mortem interval: 7 hours</value><value>Post-mortem interval: 81 hours</value><value>Post-mortem interval: 84 hours</value><value>Post-mortem interval: 85 hours</value><value>Post-mortem interval: 8 hours</value><value>Post-mortem interval: 9.2 hours</value><value>Post-mortem interval: 91 hours</value><value>Post-mortem interval: 96 hours</value><value>Post-mortem interval: 97 hours</value></sampleattribute><sampleattribute><category>ClinicalTreatment</category><value>Antipsychotics: atypical</value><value>Antipsychotics: none</value><value>Antipsychotics: typical</value><value>Antipsychotics: unknown</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>reference</value><value>schizophrenia</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>brain</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><sampleattribute><category>TimeUnit</category><value>seconds</value><value>years</value></sampleattribute><experimentalfactor><name>ClinicalTreatment</name><value>atypical antipsychotics</value><value>no antipsychotics</value><value>typical antipsychotics</value><value>unknown antipsychotics</value></experimentalfactor><experimentalfactor><name>DiseaseState</name><value>reference</value><value>schizophrenia</value></experimentalfactor><miamescores><reportersequencescore>0</reportersequencescore><factorvaluescore>1</factorvaluescore><measuredbioassaydatascore>1</measuredbioassaydatascore><protocolscore>1</protocolscore><derivedbioassaydatascore>0</derivedbioassaydatascore><overallscore>3</overallscore></miamescores><bioassaydatagroup><id>1343526859</id><name>ebi.ac.uk:MIAMExpress:FeatureDimension:22077</name><bioassaydatacubes>4</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>4</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1343526860</id><name>ebi.ac.uk:MIAMExpress:FeatureDimension:22081</name><bioassaydatacubes>3</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>3</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id>1343526861</id><name>ebi.ac.uk:MIAMExpress:FeatureDimension:22081</name><bioassaydatacubes>9</bioassaydatacubes><arraydesignprovider>MEXP</arraydesignprovider><dataformat>tab delimited</dataformat><bioassays>9</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>17822540</accession><publication>BMC Psychiatry</publication><authors>Peter Saetre; Lina Emilsson; Elin Axelsson; Johan Kreuger; Eva Lindholm; Elena Jazin</authors><title>Inflammation-related genes up-regulated in schizophrenia brains</title><year>2007</year><volume>7</volume><pages>46</pages><uri>http://dx.doi.org/10.1186/1471-244X-7-46</uri></bibliography><provider><contact>Elena Jazin</contact><email>elena.jazin@ebc.uu.se</email><role>submitter</role></provider><experimentdesign>clinical history</experimentdesign><experimentdesign>co-expression</experimentdesign><experimentdesign>disease state</experimentdesign><experimenttype>transcription profiling</experimenttype><description><id>1343526870</id><text>(Generated description) Experiment with 16 hybridizations, using 110 samples of species [Homo sapiens], using 16 arrays of array design [KTH H. sapiens 29.8k cDNA v2, KTH H. sapiens 30.5k cDNA array v1], producing 16 raw data files and 0 transformed and/or normalized data files.</text></description><description><id>1207811869</id><text> Multiple studies have shown that brain gene expression is disturbed in subjects suffering from schizophrenia. However, disentangling disease effects from alterations caused by neuroleptics is a challenging task. &lt;br&gt; To address the issues of disease heterogeneity and the effect of antipsychotic medication, we use a large collection of 110 brain autopsy samples, subdivided according to the type of antipsychotic medication received. We use global and high-resolution mRNA quantification techniques to analyse gene expression in brain tissues. We also analyse transcription in-vitro, in cell lines before and after treatment with cytokines.&lt;br&gt; Results. We show that inflammation-related genes are up regulated in all groups of patients, including those not treated at the time of death. In particular, four co-expressed genes that are inducible by inflammatory cytokines showed increased mRNA levels, namely IFITM2, IFITM3, SERPINA3, and GBP1 (p-values from qPCR ? 0.01). We also show that these genes are expressed in oligodendrocyte and endothelial cell lines, and transcription is inducible by inflammatory cytokines in both cell lines. Our results give molecular support to the inflammatory theory of schizophrenia and suggest that inflammatory cytokines may stimulate transcription in endothelial brain cells during schizophrenia progression. Unexpectedly, inflammation-related genes may also have a role in myelin producing cells, since they are also inducible by cytokines in oligodendrocyte cell lines. Our findings encourage future research to explore whether anti-inflammatory agents can be used in combination with traditional antipsychotics for a more efficient treatment of schizophrenia. </text></description><description><id>1207811875</id><text/></description><arraydesign><id>361239053</id><accession>A-MEXP-114</accession><name>KTH H. sapiens 29.8k cDNA v2</name><count>12</count></arraydesign><arraydesign><id>393920089</id><accession>A-MEXP-143</accession><name>KTH H. sapiens 30.5k cDNA array v1</name><count>4</count></arraydesign><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/microarray-as/ae/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/microarray/doc/help/programmatic_access.html
                --><raw celcount="0" count="16" name="E-MEXP-857.raw.zip"/><fgem count="0" name="E-MEXP-857.processed.zip"/><idf name="E-MEXP-857.idf.txt"/><sdrf name="E-MEXP-857.sdrf.txt"/><biosamples><png name="E-MEXP-857.biosamples.png"/><svg name="E-MEXP-857.biosamples.svg"/></biosamples></files></experiment></experiments>